Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-10

FDA Approved: ADAPALENE — Supplemental Application (Walgreens)

View source ↗

Summary

FDA approved a supplemental application for Adapalene by Walgreens, approving an additional change to the approved generic product under ANDA 090962.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)